|
Application |
Cartridge Volume (mL) | Minimum Unit Dose (mL) | Total Dose Units | Dose Range (mL) | Common Markings (Customizable Options) |
| Semaglutide | 3 | 0.0125 | 30 | 0-0.375 | 0-0.25mg-0.5mg |
| 3 | 0.0125 | 60 | 0-0.75 | 0-1.0mg、0-1.7mg、0-2.0mg、0-2.4mg、0-0.25mg-0.5mg-1.0mg | |
| Liraglutide Injection | 3 | 0.01 | 30 | 0-0.3 | 0-1.8mg、0-0.6mg-1.2mg-1.8mg |
| 3 | 0.01 | 50 | 0-0.5 | 0-0.6mg-1.2mg-1.8mg-2.4mg-3.0mg | |
| Teriparatide Injection | 3 | 0.005 | 16 | 0-0.08 | 0-80μL 、0-20mcg |
| Insulin (Glargine, Aspart, Aspart 30, Aspart 25, NPH, etc.) | 3 | 0.01 | 60 | 0-0.60 | 0-60 |
| Insulin Degludec & Liraglutide Injection | 3 | 0.01 | 50 | 0-0.5 | 0-0.6mg-1.2mg-1.8mg-2.4mg-3.0mg |
| Note | Scale markings can be customized per customer requirements. Product color can also be customized as needed. |
||||
KYD-DC1 Can Be Customized With Different Colors For The Pen Cap, Housing, And Injection Button And With Specific Printing Such As The Logo/Trademark Of The Customer.
The Most Competitive Price To Successfully Compete In An Increasingly Cost-Sensitive Market
Mature And Reliable Design To Minimize Complaint Rates And Allow A Guaranteed Pen Lifetime Of 3 Years.
Off-The-Shelf Devices Are Available Within A Few Weeks Providing An Affordable Upfront Investment For Pharmaceutical Customers.
The Dosing Mechanism Optimised For Maximum Dosing Force Reduction With Minimum Dose Knob Extension For Optimal User Experience
Large Dose Display Window For Good Readability
Bayonet Connection For Quick Cartridge Mounting
Dial And Dose Handling Concept Provides A High Level Of Patient Convenience
Audible And Tactile Feedback During Dosing, Dose Correction, And Delivery Are User-Friendly
Post-Injection Remaining Dose Indicator For The Final Dose Ensuring Correct Dosing Up To The Last Drop
